Garden City, NY, May 03, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next-generation biotech, genomics and diagnostics company, today provided an update regarding its ...
Hysteria is impossible without an audience. Panicking by yourself is the same as laughing alone in an empty room. You feel really silly.”― Chuck Palahniuk, Invisible Monsters. Today, we take our first ...
Notably, the Company currently carries only $20.1 million total accounts receivable, net on its financials. ProPhase has entered into a new revenue initiative with Crown Medical Collections. Crown ...
ProPhase Labs received a 180-day extension from Nasdaq to meet its $1.00 bid price compliance requirement. ProPhase Labs Inc. announced that it has received a 180-day extension from Nasdaq to meet the ...
ProPhase Labs, Inc. announced that CEO Ted Karkus will present at the upcoming Investor Summit Virtual on March 11, 2025, at 1:30 P.M. ET, offering investors insights into the company's operations and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results